scPharmaceuticals Inc. Annual Cost of Revenue in USD for 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: scPharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate for 2023.
scPharmaceuticals Inc. Cost of Revenue for the quarter ending June 30, 2024 was $2.3M, a 550% increase year-over-year.
scPharmaceuticals Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $6.94M.

Cost of Revenue, Trailing 12 Months (USD)

Cost of Revenue, Annual (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$3.81M			Jan 1, 2023	Dec 31, 2023	10-K	2024-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.